Claims relating to statements about artificial intelligence (“AI”) have rapidly become a focal point in securities litigation. Similar to the past surge of “greenwashing” claims tied to climate change disclosures, in 2024 we...more
4/1/2025
/ Artificial Intelligence ,
Initial Public Offering (IPO) ,
Misleading Statements ,
Misrepresentation ,
Pending Litigation ,
Publicly-Traded Companies ,
Rule 10b-5 ,
Securities Act of 1933 ,
Securities Exchange Act ,
Securities Fraud ,
Securities Litigation ,
Shareholders
On September 18, the Texas Attorney General (AG) announced a settlement agreement with Pieces Technologies, Inc. (“Pieces”), a Dallas-based healthcare artificial intelligence (AI) research and development firm, resolving...more
10/10/2024
/ Artificial Intelligence ,
Corporate Counsel ,
Enforcement Actions ,
False Statements ,
Hospitals ,
Med Tech ,
Misleading Statements ,
PHI ,
Research and Development ,
Settlement ,
State Attorneys General ,
Unfair or Deceptive Trade Practices